{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-dateTabled=2024-01-15&uin=HL2949&version=1", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?max-dateTabled=2024-01-15&uin=HL2949&version=1", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-dateTabled=2024-01-15&uin=HL2949&_metadata=all&version=1", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&max-dateTabled=2024-01-15&uin=HL2949&version=1", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-dateTabled=2024-01-15&uin=HL2949&version=1", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-dateTabled=2024-01-15&uin=HL2949&version=1", "items" : [{"_about" : "http://data.parliament.uk/resources/1536995", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1536995/answer", "answerText" : {"_value" : "

Work is continuing towards a draft Bill on reform of audit and corporate governance, for publication in due course.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4336", "label" : {"_value" : "Biography information for Lord Callanan"} } , "answeringMemberPrinted" : {"_value" : "Lord Callanan"} , "dateOfAnswer" : {"_value" : "2022-11-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-11-10T16:20:35.3Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2022-10-27", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Audit: Reform"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what progress they have made with the draft Audit Reform Bill; what resources they have allocated to drafting the bill; and when they expect to consult stakeholders on a draft of the bill.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"} ], "uin" : "HL2949"} , {"_about" : "http://data.parliament.uk/resources/1187935", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1187935/answer", "answerText" : {"_value" : "

The Department\u2019s National Institute for Health Research (NIHR) reports that as of 27 March 2020, 57 patients have been recruited to a clinical trial of treatments for patients with COVID-19 via the NIHR Clinical Research Network.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"} } , "answeringMemberPrinted" : {"_value" : "Lord Bethell"} , "dateOfAnswer" : {"_value" : "2020-04-14", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-04-14T15:45:15.083Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-03-25", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Clinical Trials"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government how many patients in the UK are taking part in clinical trials of COVID-19 treatments and vaccines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4153", "label" : {"_value" : "Biography information for Lord Kennedy of Southwark"} } , "tablingMemberPrinted" : [{"_value" : "Lord Kennedy of Southwark"} ], "uin" : "HL2949"} , {"_about" : "http://data.parliament.uk/resources/784731", "AnsweringBody" : [{"_value" : "HM Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/784731/answer", "answerText" : {"_value" : "

The behavioural response to a rise in prices is captured by the price elasticity of demand. More information on HMRC\u2019s long-run estimate of the price elasticity of demand for cigarettes can be found in HM Revenue and Custom\u2019s publication \u2018Econometric Analysis of Cigarette Consumption in the UK\u2019.<\/p>

Information on the size of the illicit market for cigarettes and hand rolling tobacco is available in HM Revenue and Custom\u2019s publication \u2018Tobacco tax gap estimates for 2016-17\u2019.<\/p>

Both of these publications may be found on the government\u2019s website.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1091", "label" : {"_value" : "Biography information for Lord Bates"} } , "answeringMemberPrinted" : {"_value" : "Lord Bates"} , "dateOfAnswer" : {"_value" : "2017-11-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-11-20T11:48:13.22Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "CaTreasury"} , "date" : {"_value" : "2017-11-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Tobacco: Excise Duties"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government, in the light of the publication by HMRC on 26 October of the Tobacco tax gap estimates 2016\u201317, what assessment they have made of the relationship between tobacco duty rises and the number of smokers seeking to purchase non-UK duty paid tobacco.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1251", "label" : {"_value" : "Biography information for Lord Naseby"} } , "tablingMemberPrinted" : [{"_value" : "Lord Naseby"} ], "uin" : "HL2949"} , {"_about" : "http://data.parliament.uk/resources/627575", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/627575/answer", "answerText" : {"_value" : "

We are not aware of any such discussions. We are aware of three supplementary protection certificates (SPCs) granted in the UK to Gilead Sciences for products involving tenofovir disoproxil fumarate, of which one has been surrendered and two are the subject of revocation proceedings.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4284", "label" : {"_value" : "Biography information for Baroness Neville-Rolfe"} } , "answeringMemberPrinted" : {"_value" : "Baroness Neville-Rolfe"} , "dateOfAnswer" : {"_value" : "2016-11-14", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-11-14T13:49:42.57Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2016-11-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Emtricitabine/Tenofovir Disoproxil"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government what discussions they have had with the pharmaceutical company Gilead Sciences about the extension of its patent for the drug tenofovir.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4171", "label" : {"_value" : "Biography information for Lord Black of Brentwood"} } , "tablingMemberPrinted" : [{"_value" : "Lord Black of Brentwood"} ], "uin" : "HL2949"} , {"_about" : "http://data.parliament.uk/resources/423485", "AnsweringBody" : [{"_value" : "Foreign and Commonwealth Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/423485/answer", "answerText" : {"_value" : "As the Secretary of State for Foreign and Commonwealth Affairs, my right hon. Friend the Member for Runnymede and Weybridge (Mr. Hammond) said on 9 October, \u201cWe condemn all acts of violence, including attacks by Palestinians and by Israeli settlers. We urge all sides to take immediate steps to de-escalate the tensions and avoid actions that threaten to exacerbate the situation\u201d. In his Statement of 13 October, the Parliamentary Under-Secretary of State for Foreign and Commonwealth Affairs, my hon. Friend the Member for Bournemouth East (Mr. Ellwood), said, \u201cWe are also concerned by the use of force by Israeli security personnel in response to protests and security incidents\u201d."} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3474", "label" : {"_value" : "Biography information for Baroness Anelay of St Johns"} } , "answeringMemberPrinted" : {"_value" : "Baroness Anelay of St Johns"} , "dateOfAnswer" : {"_value" : "2015-11-02", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-11-02T14:30:36.59Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "16"} , "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"} , "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"} , "date" : {"_value" : "2015-10-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Israel: Palestinians"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government what assessment they have made of reports regarding increasing violence towards Palestinians by Israeli troops.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3470", "label" : {"_value" : "Biography information for Lord Ahmed"} } , "tablingMemberPrinted" : [{"_value" : "Lord Ahmed"} ], "uin" : "HL2949"} , {"_about" : "http://data.parliament.uk/resources/156526", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/156526/answer", "answerText" : {"_value" : "

The Contract does not include any penalties for early termination of provision of the Azure Card.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1091", "label" : {"_value" : "Biography information for Lord Bates"} } , "answeringMemberPrinted" : {"_value" : "Lord Bates"} , "dateOfAnswer" : {"_value" : "2014-11-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-25T14:30:59.84Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2014-11-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Asylum: Finance"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government whether they would incur any contractual penalties if they were to decide to cancel the Azure Card; and if so what those penalties would be.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3691", "label" : {"_value" : "Biography information for Lord Roberts of Llandudno"} } , "tablingMemberPrinted" : [{"_value" : "Lord Roberts of Llandudno"} ], "uin" : "HL2949"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 6, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }